165 related articles for article (PubMed ID: 23849457)
1. Zinc-alpha2-glycoprotein in patients with acute and chronic kidney disease.
Sörensen-Zender I; Beneke J; Schmidt BM; Menne J; Haller H; Schmitt R
BMC Nephrol; 2013 Jul; 14():145. PubMed ID: 23849457
[TBL] [Abstract][Full Text] [Related]
2. Using circulating O-sulfotyrosine in the differential diagnosis of acute kidney injury and chronic kidney disease.
Chen S; Liu YH; Dai DP; Zhu ZB; Dai Y; Wu ZM; Zhang LP; Duan ZF; Lu L; Ding FH; Zhu JZ; Zhang RY
BMC Nephrol; 2021 Feb; 22(1):66. PubMed ID: 33622294
[TBL] [Abstract][Full Text] [Related]
3. The Therapeutic Potential of Zinc-Alpha2-Glycoprotein (AZGP1) in Fibrotic Kidney Disease.
Sörensen-Zender I; Rong S; Haller H; Schmitt R
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054830
[TBL] [Abstract][Full Text] [Related]
4. Zinc-α2-Glycoprotein Exerts Antifibrotic Effects in Kidney and Heart.
Sörensen-Zender I; Bhayana S; Susnik N; Rolli V; Batkai S; Baisantry A; Bahram S; Sen P; Teng B; Lindner R; Schiffer M; Thum T; Melk A; Haller H; Schmitt R
J Am Soc Nephrol; 2015 Nov; 26(11):2659-68. PubMed ID: 25788525
[TBL] [Abstract][Full Text] [Related]
5. Possible association between dysnatremias and mortality during hospitalization in patients undergoing acute hemodialysis: analysis from a Peruvian retrospective cohort.
Mezones-Holguin E; Niño-Garcia R; Herrera-Añazco P; Taype-Rondan Á; Pacheco-Mendoza J; Hernandez AV
J Bras Nefrol; 2019; 41(4):501-508. PubMed ID: 31528981
[TBL] [Abstract][Full Text] [Related]
6. High-sensitivity C-reactive protein and the risk of chronic kidney disease progression or acute kidney injury in post-myocardial infarction patients.
Fu EL; Franko MA; Obergfell A; Dekker FW; Gabrielsen A; Jernberg T; Carrero JJ
Am Heart J; 2019 Oct; 216():20-29. PubMed ID: 31382219
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of renal function, which and when?
Wasung ME; Chawla LS; Madero M
Clin Chim Acta; 2015 Jan; 438():350-7. PubMed ID: 25195004
[TBL] [Abstract][Full Text] [Related]
8. Zinc-α-2-glycoprotein: a candidate biomarker for colon cancer diagnosis in Chinese population.
Xue Y; Yu F; Yan D; Cui F; Tang H; Wang X; Chen J; Lu H; Zhao S; Peng Z
Int J Mol Sci; 2014 Dec; 16(1):691-703. PubMed ID: 25561225
[TBL] [Abstract][Full Text] [Related]
9. Incidence of acute kidney injury among patients with chronic kidney disease: a single-center retrospective database analysis.
Hatakeyama Y; Horino T; Kataoka H; Matsumoto T; Ode K; Shimamura Y; Ogata K; Inoue K; Taniguchi Y; Terada Y; Okuhara Y
Clin Exp Nephrol; 2017 Feb; 21(1):43-48. PubMed ID: 26879775
[TBL] [Abstract][Full Text] [Related]
10. Role of adipokine zinc-α
Huang D; Mao X; Peng J; Cheng M; Bai T; Du M; Huang K; Liu B; Yang L; Huang K; Zhang F
Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1055-E1062. PubMed ID: 31526290
[TBL] [Abstract][Full Text] [Related]
11. Serum and Urinary NGAL and Cystatin C Levels as Diagnostic Tools for Acute Kidney Injury and Chronic Kidney Disease: A Histobiochemical Comparative Study.
Sinna MM; Altaf FMN; Mosa OF
Curr Pharm Des; 2019; 25(10):1122-1133. PubMed ID: 31096894
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of human epididymis protein 4 as a novel biomarker in patients with renal dysfunction.
Wang L; Sun Y; Cai X; Fu G
Int Urol Nephrol; 2018 Nov; 50(11):2043-2048. PubMed ID: 30006786
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for community-acquired acute kidney injury in patients with and without chronic kidney injury and impact of its initial management on prognosis: a prospective observational study.
Stucker F; Ponte B; De la Fuente V; Alves C; Rutschmann O; Carballo S; Vuilleumier N; Martin PY; Perneger T; Saudan P
BMC Nephrol; 2017 Dec; 18(1):380. PubMed ID: 29287584
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor (HGF) and hemodialysis: physiopathology and clinical implications.
Libetta C; Esposito P; Martinelli C; Grosjean F; Gregorini M; Rampino T; Dal Canton A
Clin Exp Nephrol; 2016 Jun; 20(3):371-8. PubMed ID: 26676905
[TBL] [Abstract][Full Text] [Related]
15. Some biomarkers of acute kidney injury are increased in pre-renal acute injury.
Nejat M; Pickering JW; Devarajan P; Bonventre JV; Edelstein CL; Walker RJ; Endre ZH
Kidney Int; 2012 Jun; 81(12):1254-62. PubMed ID: 22418979
[TBL] [Abstract][Full Text] [Related]
16. Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study.
Akrawinthawong K; Ricci J; Cannon L; Dixon S; Kupfer K; Stivers D; Alexander P; David S; McCullough PA
Ren Fail; 2015 Mar; 37(2):187-91. PubMed ID: 25519207
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic Acid as a New Biomarker to Differentiate Acute Kidney Injury From Chronic Kidney Disease.
Akin D; Ozmen S; Yilmaz ME
Iran J Kidney Dis; 2017 Nov; 11(6):409-413. PubMed ID: 29190600
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome in ICU patients with acute kidney injury treated with renal replacement therapy: a prospective cohort study.
De Corte W; Dhondt A; Vanholder R; De Waele J; Decruyenaere J; Sergoyne V; Vanhalst J; Claus S; Hoste EA
Crit Care; 2016 Aug; 20(1):256. PubMed ID: 27520553
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of salivary markers of kidney functions in acute and chronic kidney diseases.
Kovalčíková AG; Pavlov K; Lipták R; Hladová M; Renczés E; Boor P; Podracká Ľ; Šebeková K; Hodosy J; Tóthová Ľ; Celec P
Sci Rep; 2020 Dec; 10(1):21260. PubMed ID: 33277585
[TBL] [Abstract][Full Text] [Related]
20. Survival after acute kidney injury requiring dialysis: long-term follow up.
Duran PA; Concepcion LA
Hemodial Int; 2014 Oct; 18 Suppl 1():S1-6. PubMed ID: 25330825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
